Literature DB >> 21474102

Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Frederick Anokye-Danso1, Chinmay M Trivedi, Denise Juhr, Mudit Gupta, Zheng Cui, Ying Tian, Yuzhen Zhang, Wenli Yang, Peter J Gruber, Jonathan A Epstein, Edward E Morrisey.   

Abstract

Transcription factor-based cellular reprogramming has opened the way to converting somatic cells to a pluripotent state, but has faced limitations resulting from the requirement for transcription factors and the relative inefficiency of the process. We show here that expression of the miR302/367 cluster rapidly and efficiently reprograms mouse and human somatic cells to an iPSC state without a requirement for exogenous transcription factors. This miRNA-based reprogramming approach is two orders of magnitude more efficient than standard Oct4/Sox2/Klf4/Myc-mediated methods. Mouse and human miR302/367 iPSCs display similar characteristics to Oct4/Sox2/Klf4/Myc-iPSCs, including pluripotency marker expression, teratoma formation, and, for mouse cells, chimera contribution and germline contribution. We found that miR367 expression is required for miR302/367-mediated reprogramming and activates Oct4 gene expression, and that suppression of Hdac2 is also required. Thus, our data show that miRNA and Hdac-mediated pathways can cooperate in a powerful way to reprogram somatic cells to pluripotency.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474102      PMCID: PMC3090650          DOI: 10.1016/j.stem.2011.03.001

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  34 in total

1.  Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

Authors:  Tomohisa Seki; Shinsuke Yuasa; Mayumi Oda; Toru Egashira; Kojiro Yae; Dai Kusumoto; Hikari Nakata; Shugo Tohyama; Hisayuki Hashimoto; Masaki Kodaira; Yohei Okada; Hiroyuki Seimiya; Noemi Fusaki; Mamoru Hasegawa; Keiichi Fukuda
Journal:  Cell Stem Cell       Date:  2010-07-02       Impact factor: 24.633

2.  Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes.

Authors:  Prashant Mali; Bin-Kuan Chou; Jonathan Yen; Zhaohui Ye; Jizhong Zou; Sarah Dowey; Robert A Brodsky; Joyce E Ohm; Wayne Yu; Stephen B Baylin; Kosuke Yusa; Allan Bradley; David J Meyers; Chandrani Mukherjee; Philip A Cole; Linzhao Cheng
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

3.  Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells.

Authors:  Karim Si-Tayeb; Fallon K Noto; Masato Nagaoka; Jixuan Li; Michele A Battle; Christine Duris; Paula E North; Stephen Dalton; Stephen A Duncan
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

4.  Reprogramming towards pluripotency requires AID-dependent DNA demethylation.

Authors:  Nidhi Bhutani; Jennifer J Brady; Mara Damian; Alessandra Sacco; Stéphane Y Corbel; Helen M Blau
Journal:  Nature       Date:  2010-02-25       Impact factor: 49.962

5.  A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells.

Authors:  Angel Raya; Ignasi Rodríguez-Pizà; Susana Navarro; Yvonne Richaud-Patin; Guillermo Guenechea; Adriana Sánchez-Danés; Antonella Consiglio; Juan Bueren; Juan Carlos Izpisúa Belmonte
Journal:  Nat Protoc       Date:  2010-03-11       Impact factor: 13.491

6.  Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale.

Authors:  Maria A Lagarkova; Maria V Shutova; Alexandra N Bogomazova; Ekaterina M Vassina; Evgeny A Glazov; Ping Zhang; Albert A Rizvanov; Ilya V Chestkov; Sergey L Kiselev
Journal:  Cell Cycle       Date:  2010-03-06       Impact factor: 4.534

7.  Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway.

Authors:  Ethan David Cohen; Kaori Ihida-Stansbury; Min Min Lu; Reynold A Panettieri; Peter Lloyd Jones; Edward E Morrisey
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

8.  Induced pluripotent stem cell generation using a single lentiviral stem cell cassette.

Authors:  Cesar A Sommer; Matthias Stadtfeld; George J Murphy; Konrad Hochedlinger; Darrell N Kotton; Gustavo Mostoslavsky
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

9.  Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors.

Authors:  Alessandra Moretti; Milena Bellin; Christian B Jung; Tu-Mai Thies; Yasuhiro Takashima; Alexandra Bernshausen; Matthias Schiemann; Stefanie Fischer; Sven Moosmang; Austin G Smith; Jason T Lam; Karl-Ludwig Laugwitz
Journal:  FASEB J       Date:  2009-10-22       Impact factor: 5.191

10.  Opposing microRNA families regulate self-renewal in mouse embryonic stem cells.

Authors:  Collin Melton; Robert L Judson; Robert Blelloch
Journal:  Nature       Date:  2010-01-06       Impact factor: 49.962

View more
  522 in total

Review 1.  MicroRNAs in renal development.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  Pediatr Nephrol       Date:  2012-06-02       Impact factor: 3.714

Review 2.  From microRNAs to targets: pathway discovery in cell fate transitions.

Authors:  Deepa Subramanyam; Robert Blelloch
Journal:  Curr Opin Genet Dev       Date:  2011-06-01       Impact factor: 5.578

Review 3.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 4.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

5.  Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells.

Authors:  Brooke A DeRosa; Jessica M Van Baaren; Gaurav K Dubey; Joycelyn M Lee; Michael L Cuccaro; Jeffery M Vance; Margaret A Pericak-Vance; Derek M Dykxhoorn
Journal:  Neurosci Lett       Date:  2012-03-07       Impact factor: 3.046

Review 6.  Induced neuronal cells: how to make and define a neuron.

Authors:  Nan Yang; Yi Han Ng; Zhiping P Pang; Thomas C Südhof; Marius Wernig
Journal:  Cell Stem Cell       Date:  2011-12-02       Impact factor: 24.633

Review 7.  Epigenetic landscape of pluripotent stem cells.

Authors:  Ji Woong Han; Young-sup Yoon
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

Review 8.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

Review 9.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

Review 10.  Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases.

Authors:  Alona O Cramer; Robert E MacLaren
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.